Dissolvable magnesium stents under Real-World scrutiny in major registry
NCT ID NCT04679740
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This registry is tracking over 1,100 people with coronary artery disease who receive resorbable magnesium scaffolds—stents that slowly dissolve over time. The goal is to see how well these devices work in everyday medical practice, focusing on safety and whether they keep arteries open after one year. Participants are treated according to standard guidelines, with no extra restrictions beyond the device's instructions for use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Magmaris and Freesolve resorbable magnesium scaffolds (drug-eluting devices)
- What this could lead to
- If successful, this registry could confirm that resorbable magnesium scaffolds are a safe and effective option for opening blocked heart arteries, potentially reducing the need for permanent metal stents.
- What could go wrong
- This is an observational registry, not a controlled trial, so it cannot prove the scaffolds are better than existing treatments. Risks include scaffold failure, blood clots, or the need for repeat procedures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
1 Wojskowy Szpital Kliniczny z Poliklinika SPZOZ w Lublinie
RECRUITINGLublin, Poland
-
Cairns Hospital
COMPLETEDCairns, 4870, Australia
-
Centre Hospitalier Universitaire Vaudois
RECRUITINGLausanne, 1005, Switzerland
-
Centro Cardiologico Monzino
RECRUITINGMilan, Lombardy, 20138, Italy
-
Daugavpils Regional Hospital
COMPLETEDDaugavpils, LV-5417, Latvia
-
Heart Center Segeberger Kliniken
RECRUITINGBad Segeberg, 23795, Germany
-
Herz-und Gefäßzentrum Oberallgäu-Kempten
COMPLETEDKempten, Germany
-
Klinikum Herford
COMPLETEDHerford, 32049, Germany
-
Klinikum Westfalen, Knappschaft KH
COMPLETEDDortmund, 44309, Germany
-
Krankenhaus Buchholz
COMPLETEDBuchholz, 21244, Germany
-
Lindenhofspital
RECRUITINGBern, 3001, Switzerland
-
SUSCCH Banska Bystrica
COMPLETEDBanská Bystrica, 974 01, Slovakia
-
Solothurner Spitäler AG
RECRUITINGOlten, 4600, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?
- Can a higher dose of adenosine sharpen heart scans?